Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/1999
11/03/1999EP0953645A2 Transcription factor controlling phenylpropanoid biosynthesis pathway
11/03/1999EP0953641A2 Polynucleotide molecules encoding neospora proteins
11/03/1999EP0953640A2 cDNA sequences of genes involved in the induction of resistance in plants
11/03/1999EP0953639A1 FAPalpha-specific antibody with improved producibility
11/03/1999EP0953637A2 Acetylcholine receptor
11/03/1999EP0953633A1 Cell culturing method and medium for producing proliferated, normal, differentiated human liver cells
11/03/1999EP0953632A1 Use of nanoemulsions for determination of the biocompatibility of lipophilic materials in cell culture test and nanoemulsions suitable therefor
11/03/1999EP0953354A1 Hematopoietic stem cell proliferating agents
11/03/1999EP0953351A2 Medicaments containing, as the main ingredient, allogenic activated-CD4+ cells and method for producing the same
11/03/1999EP0953049A2 Novel human metallothionein
11/03/1999EP0953048A1 Compounds for modulating cell negative regulations and biological applications thereof
11/03/1999EP0953046A1 Human hematopoietic stem and progenitor cell antigen and methods for its use
11/03/1999EP0953043A1 Genes and gene products related to werner's syndrome
11/03/1999EP0953042A1 Methods and reagents for regulating telomere length and telomerase activity
11/03/1999EP0953041A1 Serum-free mammalian cell culture medium, and uses thereof
11/03/1999EP0953040A1 Skin regeneration using mesenchymal stem cells
11/03/1999EP0952847A1 Stable biocatalysts for ester hydrolysis
11/03/1999EP0952845A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells
11/03/1999EP0952828A2 Therapeutic uses for nitric oxide inhibitors
11/03/1999EP0952772A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration
11/03/1999EP0952769A1 Diffusion gradient bioreactor and extracorporeal liver device
11/03/1999EP0952767A1 Production of somatic mosaicism in mammals using a recombinatorial substrate
11/03/1999EP0778944B1 Cell separation apparatus and method
11/03/1999EP0693121A4 Monoclonal antibody 88bv59, subclones and method of making
11/03/1999EP0660930B1 Improved method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
11/03/1999CN1234075A Retroviral vector
11/03/1999CN1234073A Circularly permuted erythropoietin receptor agonists
11/03/1999CN1234072A Anti-ErbB2 antibodies
11/03/1999CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/02/1999US5977441 Transgenic plants that have been modified such that expression of a desired introduced gene can be limited to a particular stage of plant development, a particular plant tissue, particular environmental conditions, or a particular time or
11/02/1999US5977439 Binary BAC vector
11/02/1999US5977438 Production of peptides in plants as viral coat protein fusions
11/02/1999US5977437 Genetically engineered starch producing plant or alga which produces exogenous plant or algal adenosine diphosphate-glucose pyrophosphorylase; for increased starch yield
11/02/1999US5977436 Nucleic acid which directs seed-specific expression of linked heterologous nucleic acid; for expression cassettes and vectors to modulate fatty acid synthesis or lipid metabolism in transformed plants
11/02/1999US5977338 Polynucleotides which hybridize with naturally occurring sequences encoding human interferon-inducible protein (hifi) and the polynucleotides which identify and encode hifi.
11/02/1999US5977320 Antibody to novel human phosphorylase kinase gamma subunit
11/02/1999US5977315 Murine anti-idiotype antibody 3H1
11/02/1999US5977311 53BP2 complexes
11/02/1999US5977300 Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof
11/02/1999US5977181 Enzyme inhibitors
11/02/1999US5977085 Vectors carrying coding sequence for the SpsB protein of Staphylococcus aureus
11/02/1999US5976880 Process and apparatus for the genetic transformation of cells
11/02/1999US5976879 Antisense oligonucleotides which combat aberrant splicing and methods of using the same
11/02/1999US5976875 Diacylglycerol kinase isoforms epsilon and zeta and methods of use thereof
11/02/1999US5976860 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
11/02/1999US5976849 Human E3 ubiquitin protein ligase
11/02/1999US5976840 Polynucleotides encoding gluS polypeptides of streptococcal pneumoniae
11/02/1999US5976838 Secreted proteins and polynucleotides encoding them
11/02/1999US5976837 Secreted proteins and polynucleotides encoding them
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976833 Relates to a method of producing protein or peptide by the culture of recombinant cells.
11/02/1999US5976831 Therapeutic compounds, and more particularly to soluble and membrane-bound forms of a low-affinity receptor for human immunoglobulin g, nucleic acids encoding the same. diagnostic uses of such receptors.
11/02/1999US5976826 Plate with surface pattern of cytophilic zones formed of self-assembled monolayer, and cytophobic zones wide enough to only allow contact by cellular bridges above and free of contact with cytophobic zones; for cytometry, cultures
11/02/1999US5976815 Screening drugs/ligands of activin receptor-like kinase 7 receptor by transfecting host cell with nucleic acid encoding receptor protein, contacting cell with drug/ligand, evaluating effect on kinase activity
11/02/1999US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
11/02/1999US5976808 Assays for identifying agents which affect regulators of UCP3 gene expression
11/02/1999US5976807 Eukaryotic cells stably expressing genes from multiple transfected episomes
11/02/1999US5976782 Screening substances for angiogenesis modulation activity.
11/02/1999US5976546 Antigen presenting cells activated by contact with a polypeptide complex constructed by joining together a dendritic cell-binding protein and a polypeptide antigen.
11/02/1999US5976545 ZPC polypeptides
11/02/1999US5976530 Peptide plasminogen activators
11/02/1999US5976526 Injectable bladder muscle cells-polymer suspension for treatment of vesicoureteral reflux and incontinence
11/02/1999CA2119443C Human cyclin e
10/1999
10/28/1999WO1999054738A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999WO1999054735A1 Improved immunodiagnostic assays using reducing agents
10/28/1999WO1999054493A2 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
10/28/1999WO1999054489A1 Stress tolerant plants
10/28/1999WO1999054485A1 A method for inhibiting tumor invasion or spreading in a subject
10/28/1999WO1999054481A1 Mutant having uracil phosphoribosyl transferase activity
10/28/1999WO1999054472A1 Novel insecticidal toxins from xenorhabdus nematophilus and nucleic acid sequences coding therefor
10/28/1999WO1999054471A1 Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054468A1 Soluble protein ztmpo-1
10/28/1999WO1999054467A1 Sh2 domain-containing peptides
10/28/1999WO1999054465A2 Gene encoding syntaxin interacting protein
10/28/1999WO1999054464A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
10/28/1999WO1999054463A2 Human k+ ion channel and therapeutic applications thereof
10/28/1999WO1999054461A2 Human nucleic acid sequences of endometrium tumour tissue
10/28/1999WO1999054460A2 Human nucleic acid sequences of normal bladder tissue
10/28/1999WO1999054459A2 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
10/28/1999WO1999054457A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates
10/28/1999WO1999054448A2 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue
10/28/1999WO1999054447A2 Human nucleic acid sequences of bladder tumour tissue
10/28/1999WO1999054446A2 Human nucleic acid sequences which are overexpressed in normal pancreas tissue
10/28/1999WO1999054445A2 Combination therapy using nucleic acids and conventional drugs
10/28/1999WO1999054440A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
10/28/1999WO1999054439A1 Isolation and purging of cells by means of osmotic pressure
10/28/1999WO1999054435A2 Immortalised cell lines derived from normal human skin tissues
10/28/1999WO1999054359A1 Matrix binding factor
10/28/1999WO1999054353A2 Human nucleic acid sequences of normal uterus tissue
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999054349A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999WO1999054348A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999WO1999054342A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
10/28/1999WO1999053955A1 Creation of bioactive surfaces through selective adsorption
10/28/1999WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
10/28/1999WO1999041404A3 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
10/28/1999WO1999041379A9 Members of the d52 gene family
10/28/1999WO1999041378A9 Members of the d52 gene family
10/28/1999WO1999040946A3 Methods and compositions for modulating leptin activity